gliclazide has been researched along with Kidney Diseases in 1 studies
Gliclazide: An oral sulfonylurea hypoglycemic agent which stimulates insulin secretion.
Kidney Diseases: Pathological processes of the KIDNEY or its component tissues.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Taghizadeh, F | 1 |
| Hosseinimehr, SJ | 1 |
| Zargari, M | 1 |
| Karimpour Malekshah, A | 1 |
| Talebpour Amiri, FB | 1 |
1 other study available for gliclazide and Kidney Diseases
| Article | Year |
|---|---|
Gliclazide attenuates cisplatin-induced nephrotoxicity through inhibiting NF-κB and caspase-3 activity.
Topics: Animals; Antineoplastic Agents; Caspase 3; Cisplatin; Gene Expression Regulation; Gliclazide; Hypogl | 2020 |